The Merck Digital Sciences Studio (MDSS) is a nine-month accelerator that invests in and supports early-stage startups developing digitally enabled technologies for drug discovery, pre-clinical, and clinical development.
Selected startups gain direct access to Merck experts, personalized mentoring from Centech advisors, and a SAFE investment from the Merck Global Health Innovation Fund (GHI), in collaboration with regional partners The Venture Collective (United States) and CQDM (Canada). Through this collaborative approach, MDSS connects innovators, researchers, and industry leaders to accelerate breakthroughs in health technology.
Applications are now open for our 2026 cohort!
We are looking for startups building the next wave of discovery, preclinical, and translational medicine approaches aligned with Merck's therapeutics areas of focus.
Please submit your application in English and include only non-confidential information. By submitting your application, you agree that your materials are non-confidential and may be reviewed by MDSS Operators and Investors.